Diaphragmatic Electrical Activity in Preterm Infants on Non-Invasive Ventilation

NCT03422549 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-04-17

No results posted yet for this study

Summary

Preterm babies have immature lungs and frequent pauses in their breathing which often necessitates breathing support. Nasal Continuous Positive Airway Pressure (CPAP) is one of the most commonly used tools but does not always provide enough support. A new option is non-invasive high frequency ventilation (NHFOV), which gently shakes the lungs to help with gas exchange and may decrease a baby's work of breathing. The investigators plan to study very low birth weight preterm babies who are generally well but require some support with their breathing. By inserting a special feeding tube with sensors into the stomach, the investigators can measure the electrical activity of the diaphragm (EAdi), which is an important muscle for breathing. By analyzing EAdi in babies receiving either CPAP or NHFOV, the investigators will be able to measure and compare how each method of support affects a baby's breathing. This important study will help us determine the most appropriate breathing support for preterm babies.

Conditions

  • Respiratory Distress Syndrome, Newborn
  • Chronic Lung Disease of Newborn (Diagnosis)

Interventions

DEVICE

Drager VN500 Ventilator

This ventilator is capable of providing both CPAP and NHFOV support.

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    collaborator OTHER
  • University of British Columbia

    lead OTHER

Principal Investigators

  • Jonathan Wong, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
48 Hours
Max Age
90 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-12-31
Completion
2020-02-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03422549 on ClinicalTrials.gov